Home
News
Create
Screeners
Insights
Indrayani Biotech
8.
51
-0.02
(-0.23%)
Market Cap
₹38.71 Cr
PE Ratio
-5.47
Industry
FMCG
Buy
Sell
Company Performance:
1D
-0.23%
1M
-7.20%
6M
-34.18%
1Y
-65.93%
5Y
+6.37%
View Company Insights
Latest news about Indrayani Biotech
Indrayani Biotech Limited Receives SARFAESI Notice from Hinduja Leyland Finance for NPA Classification
Jan 31, 2026
Indrayani Biotech Limited disclosed receiving a SARFAESI notice from Hinduja Leyland Finance Limited for NPA classification of term loans. The company has outstanding amounts of Rs. 6.46 crore as borrower and Rs. 19.12 crore as co-borrower, with current defaults of Rs. 47.56 lakh and Rs. 1.41 crore respectively. The company is evaluating the notice and plans to take necessary actions to regularize accounts and protect stakeholder interests.
Indrayani Biotech Reports Q2FY26 Results with Mixed Performance and Board Changes
Dec 11, 2025
Indrayani Biotech Secures BSE In-Principle Approval for Rights Issue of Partly Paid-up Equity Shares
Sep 20, 2025
Indrayani Biotech's Subsidiary Secures SEBI Approval for Category II Alternative Investment Fund
Sep 16, 2025
Indrayani Biotech Reports Mixed Q1 Results: Standalone Profit Steady, Consolidated Revenue Declines
Aug 15, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation